Therapy for Autoimmunity

Currently treatments for autoimmune diseases are anti-inflammatory and immunosuppressive, although recent advances in regulatory T cell therapy have shown promise as a potential therapeutic strategy. Discover the latest research on Therapies for Autoimmunity here.

January 16, 2022
Review

Myocardial inflammation and sudden death in the inherited cardiomyopathies.

The Canadian Journal of Cardiology
William J McKenna, Alida L P Caforio
January 16, 2022
Review

Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy.

Nitric Oxide : Biology and Chemistry
George J DugbarteyAlp Sener
January 16, 2022
Review

Selected transgenic murine models of human autoimmune liver diseases.

Pharmacological Reports : PR
Katarzyna TrzosJerzy Kotlinowski
January 16, 2022

CASPR2-IgG-associated autoimmune seizures.

Epilepsia
Emilio R Garrido SanabriaDivyanshu Dubey
January 16, 2022
Review

Mesenchymal Stem Cell-Based Therapy as a New Approach for the Treatment of Systemic Sclerosis.

Clinical Reviews in Allergy & Immunology
Xiufen ZhuangYanhong Wu
January 16, 2022
Review

Therapeutic benefits of flavonoids against neuroinflammation: a systematic review.

Inflammopharmacology
HamsalakshmiSaravana Babu Chidambaram
January 16, 2022
Review

Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options.

Clinical Rheumatology
Riccardo BixioOmbretta Viapiana
January 16, 2022

An appraisal of the frequency and severity of non-infectious manifestations in primary immunodeficiencies. A study of a national retrospective cohort of 1375 patients over 10 years.

The Journal of Allergy and Clinical Immunology
Mickaël AlligonCEREDIH French PID study group
January 16, 2022
Case Report

Unusual cases of Anti-SRP necrotizing myopathy with predominant distal leg weakness and atrophy.

Neuromuscular Disorders : NMD
Orly Moshe-LilieNizar Chahin
January 15, 2022

Large-scale manufacturing and characterization of CMV-CD19CAR T cells.

Journal for Immunotherapy of Cancer
Xiuli WangRyotaro Nakamura
January 15, 2022
Review

Overview of Research on Germline Genetic Variation in Immune Genes and Cancer Outcomes.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Brittany N ChaoStefanie A Nelson
January 15, 2022

Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis.

Neurology. Neuroimmunology and Neuroinflammation
Jana RemlingerAnke Salmen
January 15, 2022
Open Access

Dysfunction of low-density neutrophils in peripheral circulation in patients with sepsis.

Scientific Reports
Ran SunBingwei Sun
January 15, 2022

Annexin A1 and its receptor gene polymorphisms in systemic lupus erythematosus in the Tunisian population.

Clinical Rheumatology
Fatma DhaffouliHatem Masmoudi
January 15, 2022
Review

Biologic and targeted therapeutics in Vitiligo.

Journal of Cosmetic Dermatology
Priyanka KaragaiahMohamad Goldust

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

© 2022 Meta ULC. All rights reserved
/feed-previews/therapy-for-autoimmunity/8242861c-7a56-461a-8a4c-bdf4ce8aa58b